Navigation Links
Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer Care
Date:4/28/2009

Shared Physicians, Diagnosis, Locations, and Research Benefit Regional Cancer Patients

NEW ORLEANS, April 28 /PRNewswire/ -- Ochsner Health System (www.ochsner.org) and LSU Health Sciences Center, New Orleans (www.lsuhsc.edu) have announced a partnership to better serve the region's cancer patients by combining clinical care and cancer research in order to advance patient treatment options and provide better access to care. This collaboration will also further the development of critical, translational research, bridging the gap between research and the delivery of new therapies by allowing research to move rapidly from the laboratory into additional early phase clinical trials and new treatments for cancer patients.

The partnership between the two medical leaders began in 2008 and is centered on combining LSUHSC, the state's largest cancer research facility, with Ochsner, the state's largest clinical cancer provider, to bring better local access to comprehensive cancer care. Patients will benefit from this partnership by having access to the latest research trials and treatments closer to home and the ability to receive comprehensive cancer care through a combined network of local physicians and neighborhood locations. LSUHSC and Ochsner patients will have access to cancer services at both organizations.

"Southeast Louisiana residents will now have a truly diverse 'team' of cancer care experts, clinical experts and research leaders, dedicated to providing compassionate and comprehensive cancer care within the local community," said Dr. John Cole, M.D., Head of Hematology/Oncology at Ochsner Medical Center and Acting Chief of Hematology/Oncology at LSU Health Sciences Center New Orleans. "By combining our expertise, patients will no longer have to travel outside Louisiana to get the most current cancer treatments or participate in potentially lifesaving clinical trials."

"The joint program will allow scientists and clinicians to jointly study the most frequent cancers in our region and design new ways to prevent, diagnose and treat them," notes Dr. Augusto Ochoa, Director of the LSUHSC Stanley S. Scott Cancer Center.

"This partnership was developed from mutual commitment to provide the best care for our communities. Ochsner and LSUHSC have a long tradition of partnership through shared medical education and research trials; however, this latest collaboration will have a more direct impact on residents lives," explains Warner Thomas, President and Chief Operating Officer of Ochsner Health System.

"LSU Health Sciences Center and Ochsner have a number of joint training programs for resident physicians," said Dr. Larry Hollier, Chancellor of LSU Health Sciences Center New Orleans. "This new initiative in clinical cancer care will expand the ability of both institutions to provide the latest diagnosis and treatment for a broad range of cancer patients. This is an important milestone in the recovery of health care services for people in the New Orleans area."


'/>"/>
SOURCE Ochsner Health System
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
2. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
3. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
4. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
5. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
6. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
7. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
9. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
10. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
11. AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... ... Cenna Bioscience Inc., an emerging biopharmaceutical company focused on the discovery and ... been selected to present at the Cavendish Global Health Impact Forum taking place February ... of the Forum is to help family offices and foundations develop and implement their ...
(Date:2/9/2016)... Feb. 9, 2016  Regenicin, Inc. (OTC Bulletin ... in the development and commercialization of regenerative cell ... and organs, recently reported the Company,s operating results ... of 2016. Lonza America , Inc. ... fiscal year in the process of consummating an ...
(Date:2/9/2016)... ... 09, 2016 , ... Clinovo , the cloud-based eClinical ... Data Capture (EDC) system ClinCaptureand its new Contract Research Organization (CRO) Partner Program ... in San Mateo, California on February 10th and 11th. Watch 2-min video ...
(Date:2/9/2016)... CA (PRWEB) , ... February 09, 2016 , ... ... strategic changes over the years and Open Access publishing is one of the ... With its 700+ open access journals and 3000+ International Conferences ...
Breaking Biology Technology:
(Date:2/9/2016)... LIVERMORE, Calif. , Feb. 9, 2016 Vigilant ... mobile license plate reader (LPR) to develop a lead in ... and commercially available LPR data to locate the suspect vehicle. ... details of the case have been omitted at the agency,s ... spokesperson for the agency explains, "Our victim was found deceased ...
(Date:2/5/2016)... DUBLIN , Feb. 5, 2016 /PRNewswire/ ... the addition of the "Global Facial ... offering. --> http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has ... Facial Recognition Market 2016-2020" report to ... Markets ( http://www.researchandmarkets.com/research/5kvw8m/global_facial ) has announced the ...
(Date:2/3/2016)... 4, 2016 --> --> ... M (105.0), up 1,187% compared with fourth quarter of 2014. ... 517.6 M (loss: 30.0). Earnings per share increased to SEK ... 537.4 M (neg: 74.7). , --> ... to SEK 2,900.5 M (233.6), up 1,142% compared with 2014. ...
Breaking Biology News(10 mins):